Lorena Riol-Blanco

Lorena Riol-Blanco

Auto-generated profile, based on publicly available information

Lorena Riol-Blanco

Department of Immunology Discovery, Genentech, Inc., South San Francisco, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MJMin Jung
Min Jung
MDMichelle Dourado
Michelle Dourado
JMJames Maksymetz
James Maksymetz
AJAmanda Jacobson
Amanda Jacobson
BLBenjamin I. Laufer
Benjamin I. Laufer
JKJoshua S. Kaminker
Joshua S. Kaminker
Sensory neurons of the dorsal root ganglion (DRG) are critical for maintaining tissue homeostasis by sensing and initiating responses to stimuli. While most preclinical studies of DRGs are conducted in rodents, much less is known about the mechanisms of sensory perception in primates. We generated a transcriptome atlas of mouse, guinea pig, cynomolgus monkey, and human DRGs by implementing a common laboratory workflow and multiple data-integration approaches to generate high-resolution cross-species mappings of sensory neuron subtypes. Using our atlas, we identified conserved core modules highlighting subtype-specific biological processes related to inflammatory response. We also identified divergent expression of key genes involved in DRG function, suggesting species-specific adaptations specifically in nociceptors that likely point to divergent function of nociceptors. Among these, we validated that TAFA4, a member of the druggable genome, was expressed in distinct populations of DRG neurons across species, highlighting species-specific programs that are critical for therapeutic development.

23 February 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ABAlessia Balestrini
Alessia Balestrini
VJVictory Joseph
Victory Joseph
MDMichelle Dourado
Michelle Dourado
RRRebecca M. Reese
Rebecca M. Reese
SSShannon D. Shields
Shannon D. Shields
LRLorena Riol-Blanco
Lorena Riol-Blanco
Despite the development of effective therapies, a substantial proportion of asthmatics continue to have uncontrolled symptoms, airflow limitation, and exacerbations. Transient receptor potential cation channel member A1 (TRPA1) agonists are elevated in human asthmatic airways, and in rodents, TRPA1 is involved in the induction of airway inflammation and hyperreactivity. Here, the discovery and early clinical development of GDC-0334, a highly potent, selective, and orally bioavailable TRPA1 antagonist, is described. GDC-0334 inhibited TRPA1 function on airway smooth muscle and sensory neurons, decreasing edema, dermal blood flow (DBF), cough, and allergic airway inflammation in several preclinical species. In a healthy volunteer Phase 1 study, treatment with GDC-0334 reduced TRPA1 agonist-induced DBF, pain, and itch, demonstrating GDC-0334 target engagement in humans. These data provide therapeutic rationale for evaluating TRPA1 inhibition as a clinical therapy for asthma.

1 April 2020 in Cell
Verified
Journal Article
Closed access
CHCasper C. Hoogenraad
Casper C. Hoogenraad
LRLorena Riol-Blanco
Lorena Riol-Blanco

10 June 2009 in Protocol Exchange
Verified
Journal Article
Open access
CDCristina Delgado-Martn
Cristina Delgado-Martn
LRLorena Riol-Blanco
Lorena Riol-Blanco
LALuis M Alonso-C
Luis M Alonso-C
JRJos Luis Rodrguez-Fernndez
Jos Luis Rodrguez-Fernndez
This protocol describes a method to detect and measure the percentage of apoptotic or live dendritic cells (DCs) in popliteal lymph nodes (PLNs). DCs labelled with fluorescent cell trackers are subcutaneously (s.c.) injected in mice. After allowing the DCs to reach the PLNs, animals are intravenously injected with FLIVOTM, a permeant fluorescent reagent that selectively marks apoptotic cells. Of note, the fluorophore moiety of the latter reagent should be selected so as its emission wavelength can be distinguished under the confocal microscope from that of the fluorescent cell tracker used to label the cells. Explanted PLN are then examined under a two-photon microscope to analyse for the presence of apoptotic cells among the DCs injected. Caspases are the key proteolytic components of the demolition machinery that cleaves vital cell substrates during apoptosis1. These proteases display in their active center a cysteine residue that is required for their activity1. Active caspases